Michael Rosenblatt

Insider Reports History

Location
Kenilworth, NJ
Signature
/s/Jason W. Joseph, Attorney-in-fact for Michael Rosenblatt
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Rosenblatt:

Company Role Class Num Shares Value Price $ Report Date Ownership
Azenta, Inc. Director Common 13,042 $859,859 $65.93 12 Feb 2024 Direct
Azenta, Inc. Director Common Stock 10,577 $613,043 $57.96 13 Feb 2023 Direct
Axcella Health Inc. Director Stock Option (Right to Buy) 40,000 19 May 2022 Direct
Rubius Therapeutics, Inc. Director Stock Option (Right to Buy) 25,000 12 May 2022 Direct
Axcella Health Inc. Director Common Stock 3,053 19 May 2022 Direct

Insider Reports Filed by Michael Rosenblatt

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AZTA Azenta, Inc. 12 Feb 2024 1 +$162,517 4 Director 13 Feb 2024, 16:10
AZTA Azenta, Inc. 13 Feb 2023 1 $0 4 Director 15 Feb 2023, 15:21
/report/000110465922063902-rosenblatt-michael-2022-05-19 Axcella Health Inc. 19 May 2022 1 $0 4 Director 23 May 2022, 16:53
/report/000110465922063900-rosenblatt-michael-2022-05-19 Axcella Health Inc. 19 May 2022 0 $0 3 Director 23 May 2022, 16:53
/report/000117911022003006-rosenblatt-michael-2022-05-12 Rubius Therapeutics, Inc. 12 May 2022 1 $0 4 Director 13 May 2022, 16:28
AZTA Azenta, Inc. 11 Feb 2022 1 $0 4 Director 09 Jun 2022, 17:07
AZTA Brooks Automation, Inc. 12 Nov 2021 1 -$323,102 4 Director 15 Nov 2021, 15:12
AZTA Brooks Automation, Inc. 13 May 2021 1 -$158,400 4 Director 14 May 2021, 16:18
/report/000117911021005314-rosenblatt-michael-2021-05-12 Rubius Therapeutics, Inc. 12 May 2021 1 $0 4 Director 13 May 2021, 20:35